Vicapsys Life Sciences, Inc. (VICP): Operating Cash Flow

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$417.5K
Year ended 2023-12-31
2019-12-31: -$970.3K2020-12-31: -$262.9K2021-12-31: -$444.0K2022-12-31: -$238.2K2023-12-31: -$417.5K-$417.5K
2019-12-31 Operating Cash Flow (USD) 2023-12-31
Period endedOperating Cash FlowChange YoYSource filing
2023-12-31-$417.5Kn/m2024-10-21, From 2023-01-01
2022-12-31-$238.2Kn/m2024-10-21, From 2022-01-01
2021-12-31-$444.0Kn/m2023-04-14, From 2021-01-01
2020-12-31-$262.9Kn/m2022-03-16, From 2020-01-01
2019-12-31-$970.3Kn/a2021-09-17, From 2019-01-01